Patents by Inventor Norman Kim

Norman Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION
    Publication number: 20240123000
    Abstract: Provided herein are compositions and methods for the treatment or prevention of pathogenic infections.
    Type: Application
    Filed: May 31, 2023
    Publication date: April 18, 2024
    Applicant: Vedanta Biosciences, Inc.
    Inventors: Jessica Schneider, Yun-Gi Kim, Bernat Olle, Shilpa Reddy, Jason Norman, Juan Patarroyo
  • Solid Forms Comprising(-)-O-Desmethylvenlafaxine And Uses Thereof
    Publication number: 20160355457
    Abstract: Solid forms comprising a compound useful in the treatment, prevention and management of various conditions and diseases are provided herein. In particular, the invention provides solid forms comprising (?)-O-desmethylvenlafaxine, including salts thereof, having utility for the treatment, prevention and management of conditions and disorders including, but not limited to, affective disorders such as depression, bipolar and manic disorders, attention deficit disorder, attention deficit disorder with hyperactivity, Parkinson's disease, epilepsy, cerebral function disorders, obesity and weight gain, incontinence, dementia and related disorders.
    Type: Application
    Filed: May 25, 2016
    Publication date: December 8, 2016
    Inventors: Michael Sizensky, Harold S. Wilkinson, John R. Snoonian, Norman Kim, Sharon M. Laughlin, Roger P. Bakale, Kevin Plunkett, Patrick Mousaw
  • Solid forms comprising (-)-O-desmethylvenlafaxine and uses thereof
    Publication number: 20090005457
    Abstract: Solid forms comprising a compound useful in the treatment, prevention and management of various conditions and diseases are provided herein. In particular, the invention provides solid forms comprising (?)—O-desmethylvenlafaxine, including salts thereof, having utility for the treatment, prevention and management of conditions and disorders including, but not limited to, affective disorders such as depression, bipolar and manic disorders, attention deficit disorder, attention deficit disorder with hyperactivity, Parkinson's disease, epilepsy, cerebral function disorders, obesity and weight gain, incontinence, dementia and related disorders.
    Type: Application
    Filed: February 21, 2008
    Publication date: January 1, 2009
    Inventors: Michael Sizensky, Harold S. Wilkinson, John Snoonian, Norman Kim, Sharon M. Laughlin, Roger P. Bakale, Kevin Plunkett, Patrick Mousou
  • Contact lens with encapsulated light-reflective particles
    Publication number: 20040150787
    Abstract: A contact lens having visually perceptible light-reflective particles encapsulated within the lens body. The particles reflect light in an irregular manner, producing a sparkle or glitter effect.
    Type: Application
    Filed: September 5, 2001
    Publication date: August 5, 2004
    Inventors: Corneliu Daniel Niculas, Nancy Kathryn Manley, Norman Kim Malone, Thomas James Kartovicky, Christopher Lynch